• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超重或肥胖个体中受控衰减参数与肝脂肪变性指标的相关性:一项初步研究。

Correlation of the controlled attenuation parameter with indices of liver steatosis in overweight or obese individuals: a pilot study.

作者信息

Ferraioli Giovanna, Tinelli Carmine, Lissandrin Raffaella, Zicchetti Mabel, Faliva Milena, Perna Simone, Perani Guido, Alessandrino Francesco, Calliada Fabrizio, Rondanelli Mariangela, Filice Carlo

机构信息

Departments of aInfectious Diseases, Ultrasound Unit bDiagnostic Imaging, Fondazione IRCCS Policlinico San Matteo, University of Pavia cClinical Epidemiology and Biometric Unit dDepartment of Internal Medicine, Fondazione IRCCS Policlinico San Matteo eDepartment of Applied Health Sciences, 'Santa Margherita' Rehabilitation Institute, University of Pavia, Pavia, Italy.

出版信息

Eur J Gastroenterol Hepatol. 2015 Mar;27(3):305-12. doi: 10.1097/MEG.0000000000000287.

DOI:10.1097/MEG.0000000000000287
PMID:25629575
Abstract

OBJECTIVE

The aim of this study was to assess the clinical relevance of the controlled attenuation parameter (CAP) by analyzing the correlations between CAP and indirect indices of liver steatosis in obese or overweight individuals.

METHODS

Consecutive participants were prospectively enrolled. BMI, waist circumference, hepatic steatosis index, fatty liver index, percent fat mass and regional fat masses as assessed by dual-energy X-ray absorptiometry (DXA), fat signal fraction as assessed by MRI, and CAP were obtained. Pearson's r coefficient was used to test the correlation between two study variables.

RESULTS

A total of 88 individuals were studied. They included 31 men [age, 50.4 years (12.9 years); BMI, 30.7 kg/m (4.8 kg/m)] and 57 women [age, 49.0 years (12.6 years); BMI, 31.4 kg/m (5.6 kg/m)]. DXA, anthropometric parameters, and fatty liver index were moderately correlated with CAP in men. In women, there was a moderate correlation of CAP with the hepatic steatosis index and anthropometric parameters and only a slight or fair correlation of CAP with DXA parameters. CAP and fat signal fraction showed a good correlation (r=0.65 in men, P=0.002; r=0.68 in women, P=0.0009).

CONCLUSION

Measurement of CAP is a reliable method for noninvasive assessment of liver steatosis, showing a correlation with other indirect markers of central obesity and a good correlation with MRI results.

摘要

目的

本研究旨在通过分析肥胖或超重个体中受控衰减参数(CAP)与肝脂肪变性间接指标之间的相关性,评估CAP的临床相关性。

方法

前瞻性纳入连续的参与者。获取体重指数(BMI)、腰围、肝脂肪变性指数、脂肪肝指数、双能X线吸收法(DXA)评估的体脂百分比和局部脂肪量、磁共振成像(MRI)评估的脂肪信号分数以及CAP。采用Pearson相关系数检验两个研究变量之间的相关性。

结果

共研究了88名个体。其中包括31名男性[年龄,50.4岁(12.9岁);BMI,30.7kg/m²(4.8kg/m²)]和57名女性[年龄,49.0岁(12.6岁);BMI,31.4kg/m²(5.6kg/m²)]。在男性中,DXA、人体测量参数和脂肪肝指数与CAP呈中度相关。在女性中,CAP与肝脂肪变性指数和人体测量参数呈中度相关,而与DXA参数仅呈轻度或中度相关。CAP与脂肪信号分数显示出良好的相关性(男性r = 0.65,P = 0.002;女性r = 0.68,P = 0.0009)。

结论

测量CAP是一种可靠的非侵入性评估肝脂肪变性的方法,与中心性肥胖的其他间接标志物相关,且与MRI结果具有良好的相关性。

相似文献

1
Correlation of the controlled attenuation parameter with indices of liver steatosis in overweight or obese individuals: a pilot study.超重或肥胖个体中受控衰减参数与肝脂肪变性指标的相关性:一项初步研究。
Eur J Gastroenterol Hepatol. 2015 Mar;27(3):305-12. doi: 10.1097/MEG.0000000000000287.
2
Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter.儿童肝脏脂肪变性的无创评估:受控衰减参数的临床价值
BMC Gastroenterol. 2017 May 4;17(1):61. doi: 10.1186/s12876-017-0617-6.
3
Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations.受控衰减参数(CAP)诊断脂肪变:5323 次检查的前瞻性研究。
J Hepatol. 2014 May;60(5):1026-31. doi: 10.1016/j.jhep.2013.12.018. Epub 2013 Dec 28.
4
Hepatic steatosis in obese Chinese children.肥胖中国儿童的肝脂肪变性
Int J Obes Relat Metab Disord. 2004 Oct;28(10):1257-63. doi: 10.1038/sj.ijo.0802734.
5
How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound.在普通人群中,控制衰减参数和脂肪肝指数评估肝脂肪变性的效果如何:与超声的相关性
Liver Int. 2014 Jul;34(6):e111-7. doi: 10.1111/liv.12305. Epub 2013 Sep 4.
6
Relationship between indices of obesity obtained by anthropometry and dual-energy X-ray absorptiometry: The Fourth and Fifth Korea National Health and Nutrition Examination Survey (KNHANES IV and V, 2008-2011).人体测量法与双能X线吸收法得出的肥胖指数之间的关系:韩国第四次和第五次全国健康与营养检查调查(2008 - 2011年韩国国家健康与营养检查调查IV和V)
Obes Res Clin Pract. 2015 Sep-Oct;9(5):487-98. doi: 10.1016/j.orcp.2014.11.002. Epub 2014 Dec 4.
7
Prevalence of hepatic steatosis in apparently healthy medical students: a transient elastography study on the basis of a controlled attenuation parameter.表面健康的医学生中肝脂肪变性的患病率:基于受控衰减参数的瞬时弹性成像研究
Eur J Gastroenterol Hepatol. 2016 Nov;28(11):1264-7. doi: 10.1097/MEG.0000000000000681.
8
Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.用于非酒精性脂肪性肝病中肝脂肪变性检测和定量的受控衰减参数
J Gastroenterol Hepatol. 2014;29(7):1470-6. doi: 10.1111/jgh.12557.
9
Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.受控衰减参数(CAP):基于瞬时弹性成像的肝脂肪变性非侵入性检测方法。
Liver Int. 2012 Jul;32(6):902-10. doi: 10.1111/j.1478-3231.2012.02781.x. Epub 2012 Mar 21.
10
Noninvasive detection of hepatic steatosis in patients without ultrasonographic evidence of fatty liver using the controlled attenuation parameter evaluated with transient elastography.应用瞬时弹性成像技术测量受控衰减参数无创检测无超声脂肪肝证据的患者肝脂肪变。
Eur J Gastroenterol Hepatol. 2013 Nov;25(11):1330-4. doi: 10.1097/MEG.0b013e3283623a16.

引用本文的文献

1
A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease.一种新的营养保健品(Livogen Plus®)可改善非酒精性脂肪性肝病成年患者的肝脏脂肪变性。
J Transl Med. 2022 Aug 19;20(1):377. doi: 10.1186/s12967-022-03579-1.
2
Randomized Clinical Trial: Bergamot Citrus and Wild Cardoon Reduce Liver Steatosis and Body Weight in Non-diabetic Individuals Aged Over 50 Years.随机临床试验:佛手柑柑橘和野生蓟可减少 50 岁以上非糖尿病个体的肝脏脂肪变性和体重。
Front Endocrinol (Lausanne). 2020 Aug 11;11:494. doi: 10.3389/fendo.2020.00494. eCollection 2020.
3
-diacetylcystine ameliorates inflammation in experimental non-alcoholic steatohepatitis by regulating nuclear transcription factor kappa B activation.
二乙酰胱氨酸通过调节核转录因子κB活化改善实验性非酒精性脂肪性肝炎中的炎症。
Int J Clin Exp Pathol. 2018 Nov 1;11(11):5351-5358. eCollection 2018.
4
Clinical significance of hepatic steatosis according to coronary plaque morphology: assessment using controlled attenuation parameter.根据冠状动脉斑块形态评估肝脂肪变的临床意义:应用受控衰减参数。
J Gastroenterol. 2019 Mar;54(3):271-280. doi: 10.1007/s00535-018-1516-5. Epub 2018 Oct 4.
5
Inhibition of 5-lipoxygenase inhibitor zileuton in high-fat diet-induced nonalcoholic fatty liver disease progression model.5-脂氧合酶抑制剂齐留通对高脂饮食诱导的非酒精性脂肪性肝病进展模型的抑制作用。
Iran J Basic Med Sci. 2017 Nov;20(11):1207-1212. doi: 10.22038/IJBMS.2017.9482.
6
Controlled attenuation parameter and magnetic resonance spectroscopy-measured liver steatosis are discordant in obese HIV-infected adults.在肥胖的 HIV 感染成年人中,受控衰减参数和磁共振波谱测量的肝脂肪变性不一致。
AIDS. 2017 Sep 24;31(15):2119-2125. doi: 10.1097/QAD.0000000000001601.